1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68C91B03EBD6AEB2965257979003B9D26
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/how-pharmaceutical-and-medical-device-leaders-use-respond-to-external-communications?opendocument
18
19opendocument
2034.230.84.215
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Business Communications External Communication Excellence

Best Practices in Reaching Busy Executives: How Pharmaceutical and Medical Device Leaders Use and Respond to External Communications

ID: PSM-276


Features:

Info Graphics

88 Data Graphics

450+ Metrics

Narratives

Best Practices


Pages: 64


Published: Pre-2013


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Pharmaceutical and medical device leaders strive constantly to formulate an effective communication strategy for achieving organizational success and efficiency. However, over the years due to continuous technological advances the communication process has evolved to the stage where it becomes complex for pharmaceutical companies to identify the most the preferred and effective channels for external communications.


Best Practices, LLC conducted this research study to explore the most effective and preferred B-2-B channels & tools of communication, optimum communication frequencies for B-2-Bcommunications. Specifically, this new report benchmarks the tools and usage frequency that pharmaceutical and medical executives are making use of for external communication.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Consulting; Banking; Financial Services; Insurance; Non-Profit; Chemical; Business; Professional Services; Manufacturing; Distribution; Transportation; Education; Market Research; Marketing; Public Relations; Architecture; Engineering; Communications; Aerospace; Automobile; Aviation; Computer Software; Telecommunications; Medical Device; Government; Military; Advertising; Defense; Science; Clinical Research


Companies Profiled:
Abbott; Sanofi Pasteur; Gardner Assocites; Target Point ltd; AllianceBernstein; The Aspen Institute; Economic Opportunities Program; Genentech/Roche; The Bluestar Group; AsiaConnect; The Gordon Group; General Products Corp.; Union National Bank; Zogenix; Hertz Corporation; Assessment & Information group; Jefferson Associates Inc; Pearson; Kadmon Pharmaceuticals; Barr Engineering; Kiernan Group; Inc.; Xanodyne Pharmaceuticals; Kimble Chase LLC; Bayer Corporation; MedPanel; Bee Tree Consulting; MESCO; ltd; Nationwide Financial; Biotest Pharmaceuticals; Omicron Canada Inc.; Wells Fargo; One Communications; Bosch Power Tools; Parallel Consulting; Bristow Group; Porsche Cars North Americq; Oracle; Prescience International; BT Conferencing; ProVeritas Management Consulting; Celgene Pte Ltd; Reliance Industries Limited; Johnson & Johnson; Royal Thai Air Force; CIT Group; Sales Channel Europe; Citibank; City of Houston; Pfizer; Commutateur; Corium International Inc.; Inspire Pharmaceuticals; Croda Inc; Deloitte; Quintiles; Eastwest Bank; Ethicon; Kimble Chase; Roche; Honeywell; Rockland Trust Company; KPMG; Sandoz; Cloud Currencies; HCA; Sanofi-Aventis; Lockheed Martin; Stryker; Grundfos Pumps Manufacturing Corp; Sunovion; Lundbeck; Fidelity Investments; Talecris; Genzyme; Thermo Fisher; Medtronic; Vertex Pharmaceuticals; Genentech; Vimta Labs; GlaxoSmithKline; Novartis; Olympus Corporation; Avaya; Astellas; AstraZeneca; Alcon; Bank of America; Baxter Healthcare; Becton Dickinson; Bell Canada; BioCentric; Cephalon; Countrywide Financial; Elan Corporation; EMD Serono; Exelixis


Study Snapshot

The report is based on the insights of 63 leaders from several pharmaceutical and medical device companies. Key topics include:
  • Benchmark the tools and usage frequency executives are making use of for external communication
  • Identify the preferred and effective channels for external communications

Sample Key Findings

PowerPoint Continues to Dominate: Respondents prefer that information be communicated through PowerPoint than other forms, followed closely by Word Documents. Press Releases are unfavored.
  • The Impact of Face-to-Face Communication: 9 in 10 of those surveyed stated that meeting someone in person has an impact on their purchasing decisions. Conversely, telemarketing and mobile marketing have the least impact on purchasing decisions.
Table of Contents

Project Overview
  • Key Insights
  • About Benchmark Class
  • External Communication: Tools and Usage Frequency
  • External Communication: Preference and effectiveness
  • Appendix
    • Additional Quotes
    • About Best Practices